Dayforce (DAY), a bio-tech and software company, has seen numerous significant events and developments recently. The company's valuation has risen due to expanded partnerships with companies like
Emburse and
DocuSign. Thoma Bravo, an American private equity firm, is set to finalize an imposing $12.3 billion acquisition of Dayforce Inc, marking one of the largest deals in the tech sphere. More than 88% of Dayforce's holders approved the deal, and the samem got completed recently. Despite the earlier opposition from one of Dayforce's largest investors,
T. Rowe Price, and ensuing legal battles, the
merger completion is imminent. Amid these strategic moves, Dayforce continues to expand its operations and
partnership network with giants like
Microsoft and
Deloitte, emphasizing its dedication to growth and innovation. However, the company is facing some scrutiny over its
stock buyout valuation and has been the subject of several investigations seeking to protect shareholders' rights. Most recently, the company announced the completion of the Thoma Bravo take-private merger.
Dayforce DAY News Analytics from Fri, 22 Apr 2022 07:00:00 GMT to Sat, 28 Mar 2026 12:01:30 GMT -
Rating 8
- Innovation 7
- Information 8
- Rumor -3
